Intervention Review

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement

  1. Carlos A Salazar1,*,
  2. German Malaga2,
  3. Giuliana Malasquez2

Editorial Group: Cochrane Peripheral Vascular Diseases Group

Published Online: 14 APR 2010

Assessed as up-to-date: 11 MAR 2010

DOI: 10.1002/14651858.CD005981.pub2


How to Cite

Salazar CA, Malaga G, Malasquez G. Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement. Cochrane Database of Systematic Reviews 2010, Issue 4. Art. No.: CD005981. DOI: 10.1002/14651858.CD005981.pub2.

Author Information

  1. 1

    Universidad Peruana Cayetano Heredia, Department of Medicine, Lima, Peru

  2. 2

    Universidad Peruana Cayetano Heredia, Lima, Peru

*Carlos A Salazar, Department of Medicine, Universidad Peruana Cayetano Heredia, Avenida Honorio Delgado 430, San Martin de Porres, Lima, Peru. caso90@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 14 APR 2010

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.